Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Genomics

NIH Accelerates the Use of Genomics Sequencing in Clinical Care

Bethesda, MD, August 21, 2017 — The National Institutes of Health (NIH) on August 8 announced it is awarding $18.9 million towards research that aims to accelerate the use of genome sequencing in clinical care.

The new awards will generate innovative approaches and best practices to ensure that the effectiveness of genomic medicine can be applied to all individuals and groups, including diverse and underserved populations, and in healthcare settings that extend beyond academic medical centers. Continue reading

NIH to Expand Critical Catalog for Genomics Research to Aid Research in Health, Diseases

Bethesda, MD, February 10, 2017 — The National Institutes of Health plans to expand its Encyclopedia of DNA Elements (ENCODE) Project, a genomics resource used by many scientists to study human health and disease.

Funded by the National Human Genome Research Institute (NHGRI), part of NIH, the ENCODE Project is generating a catalog of all the genes and regulatory elements — the parts of the genome that control whether genes are active or not — in humans and select model organisms.

With four years of additional support, NHGRI builds on a long-standing commitment to developing freely available genomics resources for use by the scientific community. Continue reading

Rutgers Board of Governors Approves New Chairs in Cancer Genomics, Alzheimer’s Disease and Philosophy of Religion

Rutgers SealNew Brunswick, NJ, June 15, 2016 — The Rutgers University Board of Governors has approved the establishment of three new endowed chairs in cancer genomics, Alzheimer’s disease and neurodegeneration research and the philosophy of religion.

The three new chairs have been endowed by foundations and individual donors. Each of the gifts has been matched by $1.5 million from an anonymous donor as part of an earlier $27 million challenge grant to create a total of 18 new endowed chairs at Rutgers.

The Duncan and Nancy MacMillan Endowed Chair in Cancer Genomics was established with a $1.5 million gift from an anonymous donor.  The MacMillans, for whom the chair is named, have been generous supporters of Rutgers University for many years.

Housed in the Department of Genetics in Rutgers University-New Brunswick’s School of Arts and Sciences, the chair will enhan Continue reading

Rutgers’ Human Genetics Institute Lab Expands into Clinical Testing, Earns Federal Certification

New Brunswick, NJ, July 10, 2014RUCDR Infinite Biologics, a unit of Rutgers’ Human Genetics Institute of New Jersey, has taken a major step toward expanding its focus from conducting and supporting genomic research, where it’s become a recognized global leader, to the rapidly growing field of clinical genomics.

RUCDR, which is the world’s largest university-based biorepository, recently earned its initial certification from the federal Clinical Laboratory Improvement Amendments program.  CLIA, as it’s commonly known in health care, is run by the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services. Continue reading